The effect of chloral hydrate (CH)-induced sleep on inspiratory drive has not been systematically assessed. To determine the effects of CH on the ventilatory responses to hypercarbia and to hypoxia, nine unanesthetized adult rabbits with chronic tracheostomy were studied. We compared awake ventilatory measurements before CH to non-REM sleep assessments at 30, 60, 90, and 120 rnin after administration of 250 mg/kg of CH. There were no significant differences between any of these assessment intervals for respiratory rate, PAcoz, pA02) tidal volume (VT), minute volume, Ti/TtOt, or VT/T~. Hypercarbic ventilatory response slopes were not diminished at any of the CH-sleep intervals compared to the awake mean slope. In addition, the ventilatory response to hypoxia at PAoz = 70 mm Hg (V70) and the hypoxic response slope demonstrated no significant decrease at any of the CH-sleep intervals. In summary, absence of any significant decrease in either hypercarbic or hypoxic ventilatory response after CH administration indicates absence of any CH effect on chemical inspiratory drive.
Summary
The effect of chloral hydrate (CH)-induced sleep on inspiratory drive has not been systematically assessed. To determine the effects of CH on the ventilatory responses to hypercarbia and to hypoxia, nine unanesthetized adult rabbits with chronic tracheostomy were studied. We compared awake ventilatory measurements before CH to non-REM sleep assessments at 30, 60, 90, and 120 rnin after administration of 250 mg/kg of CH. There were no significant differences between any of these assessment intervals for respiratory rate, PAcoz, pA02) tidal volume (VT), minute volume, Ti/TtOt, or VT/T~. Hypercarbic ventilatory response slopes were not diminished at any of the CH-sleep intervals compared to the awake mean slope. In addition, the ventilatory response to hypoxia at PAoz = 70 mm Hg (V70) and the hypoxic response slope demonstrated no significant decrease at any of the CH-sleep intervals. In summary, absence of any significant decrease in either hypercarbic or hypoxic ventilatory response after CH administration indicates absence of any CH effect on chemical inspiratory drive.
Speculation
Sedation with chloral hydrate is an acceptable means of facilitating sleep for clinical assessments of chemical inspiratory drive. Chloral hydrate may also be the preferred drug whenever a sedative-hypnotic agent is necessary in patients with precarious pulmonary status or marginal central ventilatory drive.
Chloral hydrate (CH) is generally assumed not to diminish chemical inspiratory drive, even when used in hypnotic doses. Although the use of CH would facilitate assessments of ventilatory control during sleep and has indeed been used for this purpose, studies confirming the absence of CH-related impairment of chemical inspiratory drive are not available. The following study conducted in adult unanesthetized rabbits was designed to assess the effect of CH on the ventilatory response to hypercarbia and to hypoxia.
MATERIALS AND METHODS
These studies were conducted in nine adult rabbits. A tracheostomy was performed using a 10 cm long, 4.5 mm in diameter endotracheal tube. The tube was tunnelled subcutaneously to exit in the upper, lateral neck region in order to ensure optimal tube fixation and to facilitate later attachment of the pneumotachograph without disturbing the animal.
Ventilatory response studies were performed 24-72 hr after tracheostomy. All assessments were pereformed while the rabbit was restrained in a small cage. Body temperature was maintained at a constant rectal temperature of 39°C. Based on available pharmacokinetic studies (6, 7), a CH dose of 250 mg/kg was selected. The CH was administered by nasogastric tube. All sleeping ventilatory measurements were initiated during non-REM sleep as determined by standard behavioral criteria and a stable respiratory pattern. A heated Fleisch pneumotachograph (no. 00) was used for measurement of flow and tidal volume (2) and a mass spectrometer was used for end-tidal (A) Po2 and Pcoz determinations (1) .
Measurements of respiratory frequency (f), P,coz and PAos, inspiratory time (Ti), Ti/TtOt, tidal volume (VT), and VT/T~ were recorded at each assessment interval. Twelve steady-state normoxic hypercarbic ventilatory slope responses were obtained in the nine rabbits. After a 1-min baseline recording, each animal breathed 5% COz for 4 rnin and multiple measurements of VI and corresponding PAcoz were obtained. After a 6-min recovery interval after the hypercarbic ventilatory responses, repeat baseline values were recorded for 1 rnin and VI and P,oz were then continuously recorded in five rabbits during 4 min of 15% Oz -breathing.
To coincide with a time interval at which CH and trichloroethan01 blood levels should have been maximal (6, 7) , the initial ventilatory responses in seven experiments were obtained while clinically asleep, 30 rnin after CH administration. Repeat sleep measurements were then obtained 60, 90, and 120 min after CH administration. In five rabbits, the initial ventilatory responses were obtained while awake, just before CH administration.
The hypercarbic ventilatory responses were analyzed by the method of least squares and expressed as the slope of the relationship between VI and PAcoz (ml/kg/min/mm Hg PAco~). Hypoxic ventilatory sensitivity (2) was analyzed in two ways; first we calculated the % increase in baseline Vr achieved when the PA02 fell to 70 mm Hg (V70), and second, we determined the slope of the linear relationship between VI and PAoz (ml/kg/min/mm Hg PAo2). Group means (+ S.E.) were calculated for each variable at each assessment interval. Differences between the awake results and those obtained asleep 30 rnin after CH, and differences between the sleeping results at 30 minutes compared to later values at 60, 90, and 120 min, were analyzed by Student's t test. Single-tailed analysis was used and statistical significance was considered to be <0.05.
RESULTS
The mean baseline values at each assessnlent interval for f, PAco2, Pa02, VT, inspiratory minute volume (Vr), Ti/Ttot and VT/ Ti are summarized in Table 1 . For each variable, the awake values were not significantly different compared to the peak CH (30 min) values and the peak CH values were not significantly different from the subsequent sleeping values at 60, 90, and 120 min after CH administration. Although the mean awake VI does appear to be significantly less than at the later sleep intervals, the SDs are large and none of these differences is statistically significant. No significant differences in the hypercarbic ventilatory slope responses were observed at any of the assessment intervals. Since the mean slopes at 60 and 90 min, 35 f 7 and 42 f 9, respectively, were not significantly different than the peak (30 min) or minimal CH blood level interval (120 min), only the awake, 30 and 120 rnin values are included in Figure 1 .
Hypoxic ventilatory responses were obtained awake and then asleep 30 and 60 min after CH. Assessment intervals beyond 60 min could not be obtained because these rabbits then awakened (aroused) in response to breathing 15% 02. Ventilatory sensitivity was initially assessed by calculation of v70 (Fig. 2) . Although the mean ~7 0 at 30 and at 60 rnin was less than while awake, neither of these differences was statistically significant (P = 0.15 and P > 0.30, respectively).
Hypoxic ventilatory responsivity was also assessed by linear regression analysis. As has been observed in infants (2) , the relationship between VI and P,02 was linear within the P,oz range assessed. The mean slopes obtained at 30 and 60 min were nearly identical (Fig. 3 ) and the small decreases in the CH-sleep mean slopes compared to the awake mean slope were not statistically significant ( P > 0.25 and P > 0.20, respectively).
DISCUSSION
In previously tracheostomized unanesthetized adult rabbits, we did not demonstrate significant alterations in any baseline respiratory variables during air breathing before versus 120 min after CH administration. In particular, measurements of Ti/TtOt or "duty cycle" revealed no alterations in inspiratory timing and measurement of mean inspiratory flow (VT/T~) revealed no differences in awake versus either peak or minimal CH sleeping values. Since VT/T~ is an indicator of central inspiratory drive (5), the absence of any CH-related decrease in this variable is indicative of absence of any CH-induced decrease in central inspiratory drive.
The effect of CH on chemical inspiratory drive was also examined by measuring both the hypercarbic and hypoxic ventilatory responses. Although different absolute values for hypercarbic and for hypoxic sensitivity would likely be obtained using other methods (rebreathing, hyperoxic hypercarbia, or eucapneic hypoxia), the focus of our analysis is not the absolute values obtained but rather the relative changes occurring in relation to CH administration.
The absence of any discernible decrease in hypercarbic venti- latory response slope consequent to CH administration indicates that CH did not .impair central inspiratory drive. Although normative data for v70 or hypoxic response slopes are not available for comparison with our hypoxic responsivity measurements, the absence of any statistically significant CH-related decreases indicates that CH does not impair hypoxic responsivity.
No CH blood levels were obtained. Previous pharmacokinetic studies in rabbits using the same oral dose as in our study have shown, however, that the average time required to achieve the fourth stage of anesthesia was 9.3 min and the blood half-life of trichloroethanol, the primary metabolite, was approximately 70 min (7) . In another study the maximum CH blood level after oral administration was achieved at 15 min and the peak level of trichloroethanol was reached at 30 min (6) . Any depressant effect of CH on inspiratory drive should therefore have been maximal 15-30 rnin after administration and the assessment intervals we selected should have been quite sufficient to identify any such CH-related depressant effect.
The absence of a CH-associated decrease in hypercarbic responsivity which we have observed in adult rabbits is consistent with recent studies by Lees et a1 (4) . They administered CH (100 mg/kg) to puppies and, as assessed at 60 min, showed no difference in hypercarbic ventilatory response slopes (4) . Subsequent studies in nine infants who received 50 mg/kg also documented absence of any change in hypercarbic response slope compared to nine other infants assessed during natural sleep (3). They did not, however, compare hypercarbic response slopes at peak CH blood levels to slope responses obtained either awake or while asleep but at progressively lower blood levels.
In summary, ventilatory measurements in adult rabbits have not revealed any discernible CH effect on hypercarbic sensitivity or any significant CH-related impairment of hypoxic sensitivity. We thus conclude that CH sedation is an acceptable means of facilitating sleep for clinical assessments of chemical inspiratory drive. CH may also be the drug of choice in patients with impaired pulmonary status or diminished central ventilatory drive whenever a sedative-hypnotic agent is needed.
